Bernard A. P. Lafont

3.1k citations

43 papers · 1.5k indexed · h-index 21

Virology top 1%
- HIV Research and Treatment 21
Immunology top 2%
- Immune Cell Function and Interaction 20
- T-cell and B-cell Immunology 18
- Immunotherapy and Immune Responses 7
Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 5
- COVID-19 Clinical Research Studies 4
Modeling and Simulation top 5%
Epidemiology top 10%
- Respiratory viral infections research 4
- Virology and Viral Diseases 4

Co-authors: Alicia Buckler‐White Malcolm A. Martin Vanessa M. Hirsch Tatsuhiko Igarashi Yoshiaki Nishimura Mark A. Miller Cécile Viboud Lone Simonsen
Cited by: Virology Immunology Infectious Diseases
Journals: Nature (1 paper)Science (1 paper)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United States France Australia

In The Last Decade

Bernard A. P. Lafont

43 papers receiving 1.5k citations

Peers

Countries citing papers authored by Bernard A. P. Lafont

Since Specialization

Citations

This map shows the geographic impact of Bernard A. P. Lafont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard A. P. Lafont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard A. P. Lafont more than expected).

Fields of papers citing papers by Bernard A. P. Lafont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard A. P. Lafont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard A. P. Lafont. The network helps show where Bernard A. P. Lafont may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bernard A. P. Lafont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard A. P. Lafont Line = papers co-authored together Bernard A. P. Lafont links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SARS-CoV-2 infection of human lung epithelial cells induces TMPRSS-mediated acute fibrin deposition Nature Communications ·Rachel I. Erickson,Chang Huang,C. Allen,Joanna Ireland,Gwynne Roth,Zhongcheng Zou,Jinghua Lu,Bernard A. P. Lafont,Nicole L. Garza,Beniah Brumbaugh,Ming Zhao,Motoshi Suzuki,L. Renee Olano,Joseph Brzostowski,Elizabeth R. Fischer,Homer L. Twigg,Reed F. Johnson,Peter D. Sun	2023	8
2	Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets Science ·Nunziata Maio,Bernard A. P. Lafont,Debangsu Sil,Yan Li,J. Martin Bollinger,Carsten Krebs,Theodore C. Pierson,W. Marston Linehan,Tracey A. Rouault	2021	82
3	A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters Proceedings of the National Academy of Sciences ·Xueqiao Liu,Cindy Luongo,Yumiko Matsuoka,Hong-Su Park,Celia Santos,Lijuan Yang,Ian N. Moore,Sharmin Afroz,Reed F. Johnson,Bernard A. P. Lafont,Craig Martens,Sonja M. Best,Vincent J. Munster,Jaroslav Hollý,Jonathan W. Yewdell,Cyril Le Nouën,Shirin Munir,Ursula J. Buchholz	2021	37
4	Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge The Journal of Experimental Medicine ·Kerry L. Hilligan,Sivaranjani Namasivayam,Chad S. Clancy,Danielle O’Mard,Sandra D. Oland,Shelly J. Robertson,Paul J. Baker,Ehydel Castro,Nicole L. Garza,Bernard A. P. Lafont,Reed F. Johnson,Franca Ronchese,Katrin D. Mayer-Barber,Sonja M. Best,Alan Sher	2021	69
5	Nomenclature report 2019: major histocompatibility complex genes and alleles of Great and Small Ape and Old and New World monkey species Immunogenetics ·Natasja G. de Groot,Ńel Otting,Giuseppe Maccari,James Robinson,John A. Hammond,Antoine Blancher,Bernard A. P. Lafont,Lisbeth A. Guethlein,Emily E. Wroblewski,Steven G. E. Marsh,Takashi Shiina,Lutz Walter,Linda Vigilant,Peter Parham,David H. O’Connor,Ronald E. Bontrop	2019	21
6	Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets Science Immunology ·Chuanfeng Wu,Diego A. Espinoza,Samson Koelle,Di Yang,Lauren L. Truitt,Heinrich Schlums,Bernard A. P. Lafont,Jan Davidson‐Moncada,Rong Lu,Amitinder Kaur,Quirin Hammer,Brian Li,Sandhya R. Panch,David Allan,Robert E. Donahue,Richard Childs,Chiara Romagnani,Yenan T. Bryceson,Cynthia E. Dunbar	2018	36
7	Nomenclature report on the major histocompatibility complex genes and alleles of Great Ape, Old and New World monkey species Immunogenetics ·Natasja G. de Groot,Ńel Otting,James Robinson,Antoine Blancher,Bernard A. P. Lafont,Steven G. E. Marsh,David H. O’Connor,Takashi Shiina,Lutz Walter,David I. Watkins,Ronald E. Bontrop	2012	78
8	Early Short-Term Antiretroviral Therapy Is Associated with a Reduced Prevalence of CD8 ⁺ FoxP3 ⁺ T Cells in Simian Immunodeficiency Virus-Infected Controller Rhesus Macaques AIDS Research and Human Retroviruses ·Jeffy George,Egidio Brocca Cofano,Elizabeth A. Lybarger,Mark K. Louder,Bernard A. P. Lafont,John R. Mascola,Marjorie Robert-Guroff,Joseph J. Mattapallil	2010	18
9	Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection Mucosal Immunology ·N R Klatt,L. D. Harris,Carol L. Vinton,Hannah C. Sung,Judith A. Briant,Brian Tabb,David R. Morcock,John W. McGinty,Jeffrey D. Lifson,Bernard A. P. Lafont,M A Martin,A D Levine,John D. Estes,Jason M. Brenchley	2010	108
10	Removal of either N-glycan site from the envelope receptor binding domain of Moloney and Friend but not AKV mouse ecotropic gammaretroviruses alters receptor usage Virology ·Ryan C. Knoper,John R. Ferrarone,Yuhe Yan,Bernard A. P. Lafont,Christine A. Kozak	2009	7
11	The locus encoding an oligomorphic family of MHC-A alleles (Mane-A06/Mamu-A05) is present at high frequency in several macaque species Immunogenetics ·Bernard A. P. Lafont,Christopher M. McGraw,Sabriya Stukes,Alicia Buckler‐White,Ronald J. Plishka,Russell Byrum,Vanessa M. Hirsch,Malcolm A. Martin	2007	16
12	MHC class I allele frequencies in pigtail macaques of diverse origin Immunogenetics ·Bridget Pratt,David H. O’Connor,Bernard A. P. Lafont,Joseph L. Mankowski,Caroline S. Fernandez,Retno Triastuti,Andrëw G. Brööks,Stephen J. Kent,Miranda Z. Smith	2006	35
13	Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a Smoldering Pandemic The Journal of Infectious Diseases ·Cécile Viboud,Rebecca F. Grais,Bernard A. P. Lafont,Mark A. Miller,Lone Simonsen,(unknown)	2005	173
14	Tat-neutralizing versus Tat-protecting antibodies in rhesus macaques vaccinated with Tat peptides Vaccine ·Guillaume Belliard,Bruno Hurtrel,Emmanuel Moreau,Bernard A. P. Lafont,Valérie Monceaux,B P Roques,Claude Des̀granges,Anné-Marie Aubertin,Roger Le Grand,Sylviane Muller	2004	9
15	Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants Immunogenetics ·Bernard A. P. Lafont,Alicia Buckler‐White,Ron Plishka,Charles E. Buckler,Malcolm A. Martin	2004	15
16	Characterization of Pig-Tailed Macaque Classical MHC Class I Genes: Implications for MHC Evolution and Antigen Presentation in Macaques The Journal of Immunology ·Bernard A. P. Lafont,Alicia Buckler‐White,Ron Plishka,Charles E. Buckler,Malcolm A. Martin	2003	27
17	In vivo inactivation of Nef ITAM motif of chimeric simian/human immunodeficiency virus SHIVsbg-YE correlates with absence of increased virulence in chinese rhesus macaques Virology ·Bernard A. P. Lafont,Liliane Gloeckler,Christian Beyer,Sylvain Einius,Jean Pierre Gut,Anne Marie Aubertin	2003	1
18	Implication of the C-Terminal Domain of Nef Protein in the Reversion to Pathogenicity of Attenuated SIVmacBK28-41 in Macaques Virology ·Bernard A. P. Lafont,Yves Rivière,Liliane Gloeckler,Christian Beyer,Bruno Hurtrel,Marie Paule Kiény,André Kirn,Anne Marie Aubertin	2000	8
19	One-round determination of seven leukocyte subsets in Rhesus macaque blood by flow cytometry Cytometry ·Bernard A. P. Lafont,Liliane Gloeckler,Jean Luc D'Hautcourt,Jean Pierre Gut,Anne Marie Aubertin	2000	13
20	A functional measles virus replication and transcription machinery encoded by the vaccinia virus genome Journal of Virological Methods ·Paul M. Howley,Bernard A. P. Lafont,Danièle Spehner,Karin Kaelin,Martin Billeter,Robert Drillien	1999	7

About Bernard A. P. Lafont

Bernard A. P. Lafont is a scholar working on Virology, Immunology and Infectious Diseases, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (18 papers), Immunotherapy and Immune Responses (7 papers), HIV/AIDS Research and Interventions (5 papers), Respiratory viral infections research (4 papers), Virology and Viral Diseases (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Virology (622 citations), Immunology (920 citations) and Infectious Diseases (379 citations). Bernard A. P. Lafont has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Alicia Buckler‐White, Malcolm A. Martin, Vanessa M. Hirsch, Tatsuhiko Igarashi, Yoshiaki Nishimura, Mark A. Miller, Cécile Viboud, Lone Simonsen, Rebecca F. Grais and Charles E. Buckler. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact